September 10, 2007Open Access

Functional, Cellular, and Molecular Characterization of the Angiogenic Response to Chronic Myocardial Ischemia in Diabetes

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Diabetes results in a profound impairment in the myocardial angiogenic response to chronic ischemia. Pro- and antiangiogenic mediators identified in this study offer novel targets for the modulation of the angiogenic response in diabetes.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Boodhwani et al. (Mon,) studied this question.

synapsesocial.com/papers/69d91c61ea2783c07da3c215 https://doi.org/https://doi.org/10.1161/circulationaha.106.680157

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1IMPAIRED ENDOTHELIUMDEPENDENT VASODILATION IN PATIENTS WITH INSULINDEPENDENT DIABETES MELLITUS1993 · 115 citations
2Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus2002 · 57 citations
3PARP as a drug target for the therapy of diabetic cardiovascular dysfunction2002 · 53 citations
4The Role of Poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes2002 · 284 citations
5Prevention Conference VI: Diabetes and Cardiovascular Disease2002 · 73 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo